Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative dapagliflozin to prevent postoperative acute kidney injury after cardiac surgery
2022-002453-25Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute kidney failure (AKF) comparing Dapagliflozin with Placebo (2 arms). Primary endpoint: Incidence of acute kidney injury within 7 days after surgery. Started Feb 2023; status: active.
02
Drugs
dapagliflozin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2022-002453-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002453-25.